-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Shuttle Pharmaceuticals Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2023.
- Shuttle Pharmaceuticals Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.05M, a 90.8% decline year-over-year.
- Shuttle Pharmaceuticals Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$7.2M, a 40.1% decline year-over-year.
- Shuttle Pharmaceuticals Holdings, Inc. annual Operating Income (Loss) for 2023 was -$5.89M, a 151% decline from 2022.
- Shuttle Pharmaceuticals Holdings, Inc. annual Operating Income (Loss) for 2022 was -$2.34M, a 34.5% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)